Visicol
Constipation, Hypophosphatemia, Parenteral Nutrition, Total + 4 more
Treatment
1 FDA approval
20 Active Studies for Visicol
Treatment for
Constipation
What is Visicol
Sodium phosphate, dibasic
The Generic name of this drug
Treatment Summary
Sodium phosphate is a type of medication that helps to stimulate a bowel movement by increasing fluid in the small intestine. It usually takes between 30 minutes and 6 hours for the laxative to work.
K Phos Neutral
is the brand name
Visicol Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
K Phos Neutral
Sodium phosphate, dibasic
1977
15
Approved as Treatment by the FDA
Sodium phosphate, dibasic, also known as K Phos Neutral, is approved by the FDA for 1 uses which include Parenteral Nutrition, Total .
Parenteral Nutrition, Total
Effectiveness
How Visicol Affects Patients
Sodium phosphate makes stools softer and easier to pass through the large intestine.
How Visicol works in the body
Sodium phosphate is believed to work by adding more substances to the intestines, which causes an imbalance of water in the intestine. This imbalance draws in more water, creating a gradient that helps speed up the intestines.
When to interrupt dosage
The prescribed dosage of Visicol is contingent upon the indicated condition, including fluid and electrolyte upkeep treatment, Fluid substitution therapy and Irrigation. The quantity of dosage is subject to the technique of administration (e.g. Liquid or Tablet, coated) laid out in the table below.
Condition
Dosage
Administration
Hypophosphatemia
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Parenteral Nutrition, Total
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Bowel preparation therapy
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Colonoscopy
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Surgical Procedures
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
severe constipation
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Constipation
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Intravenous, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Irrigant - Irrigation, Irrigation, Liquid, Solution, Topical, Solution - Intravenous, Tablet - Oral, Tablet, Injection, solution, Solution - Oral, Liquid - Irrigation, Tablet, coated - Oral, Tablet, coated, Injection, solution - Intravenous, Liquid - Oral, Rectal, Enema, Enema - Rectal, Injection, Irrigant, Injection - Intravenous, Solution - Irrigation, Kit, Intraocular, Kit; Solution - Intraocular; Irrigation, Intraocular; Irrigation, Kit; Solution - Intraocular, Kit; Solution, Powder - Oral, Powder, Powder, for solution, Liquid - Buccal, Spray, Buccal, Respiratory (inhalation), Tablet, effervescent, Spray - Buccal, Liquid - Topical, Solution - Respiratory (inhalation), Powder, for solution - Intraocular
Warnings
Visicol has four contraindications and should not be used in coordination with the conditions given in the following table.
There are 20 known major drug interactions with Visicol.
Common Visicol Drug Interactions
Drug Name
Risk Level
Description
Alloin
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Alloin.
Calcium polycarbophil
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Calcium polycarbophil.
Chlorpropamide
Minor
Sodium phosphate, dibasic may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Frangula purshiana bark
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Frangula purshiana bark.
Konjac mannan
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Konjac mannan.
Visicol Toxicity & Overdose Risk
Rats have a lethal dose of sodium phosphate of 250mg/kg when given intramuscularly and 8290mg/kg when given orally. High levels of phosphate in the body can cause tetany, dehydration, low blood pressure, rapid heartbeat, extreme fever, and even coma. Smaller patients are more at risk for experiencing phosphate toxicity.
Visicol Novel Uses: Which Conditions Have a Clinical Trial Featuring Visicol?
54 active clinical trials are ongoing to investigate the efficacy of Visicol in providing Electrolyte replacement, proctoscopy and Irrigation for treatment of certain conditions.
Condition
Clinical Trials
Trial Phases
severe constipation
0 Actively Recruiting
Bowel preparation therapy
0 Actively Recruiting
Colonoscopy
3 Actively Recruiting
Not Applicable
Constipation
18 Actively Recruiting
Phase 2, Not Applicable, Phase 4, Phase 3, Phase 1
Surgical Procedures
0 Actively Recruiting
Hypophosphatemia
0 Actively Recruiting
Parenteral Nutrition, Total
0 Actively Recruiting
Visicol Reviews: What are patients saying about Visicol?
5
Patient Review
1/2/2009
Visicol for Emptying of the Bowel
4
Patient Review
11/30/2007
Visicol for Emptying of the Bowel
2
Patient Review
3/20/2009
Visicol for Emptying of the Bowel
Patient Q&A Section about visicol
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is Visicol used for?
"The VISICOL colonoscopy prep medication is only to be used by adults aged 18 and over. It works by causing diarrhea, which in turn cleans out the colon before the procedure. This is important because it allows your doctor to get a better view of the inside of the colon."
Answered by AI
Is Visicol still on the market?
"This product is no longer available under the Visicol name. If the FDA has approved generic versions of this product, there may be generic equivalents available."
Answered by AI